Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.51093
PubMed Identifier: 32513388
Publication URI: http://europepmc.org/abstract/MED/32513388
Type: Journal Article/Review
Volume: 9
Parent Publication: eLife
ISSN: 2050-084X